自膨式支架市场：现况分析与预测（2023-2030）

Self-Expandable Stents Market: Current Analysis and Forecast (2023-2030)

出版日期: 2024年03月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 132 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

自膨胀支架是用于治疗血管狭窄或闭塞的医疗器械，主要应用于介入性心臟病学和血管外科领域。与必须充气才能扩张的球囊扩张支架不同，自扩张支架设计为一旦插入血管就会自动扩张。这一特性使其在血管移动或直径变化的区域特别有用。週边动脉疾病（PAD）和冠状动脉疾病（CAD）等心血管疾病的盛行率不断上升，刺激了对支架置入等介入治疗的需求，从而促进了市场扩张。例如，根据疾病管制与预防中心的数据，60% 的美国人患有至少一种慢性疾病，如心臟病、糖尿病或癌症。此外，据报道，2021年美国将有约65万人死于心臟病。

2022 年自膨式支架市值为 32 亿美元，预估 2023 年至 2030 年复合年增长率约为 7.5%。

产品分为颈动脉自膨式支架、胃肠自膨式支架、血管内支架等。颈动脉自膨式支架细分市场在2022年占据最大的市场。颈动脉狭窄等冠状动脉疾病发生率的增加是市场的主要驱动因素之一。

依应用，市场分为股动脉、髂动脉、颈动脉、胆动脉等。其中，颈动脉应用出现了显着增长，这主要是由于越来越多地采用颈动脉支架置放术（CAS）作为颈动脉疾病的治疗选择。

依最终用户划分，市场分为医院、门诊手术中心等。其中，门诊手术中心出现快速增长，主要是由于门诊手术中心在不同地区的大量存在以及越来越多的患者选择门诊手术中心进行支架置入相关手术所致。

为了更瞭解该产业的市场采用情况，将市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、义大利、西班牙、欧洲其他地区）、亚洲太平洋地区（中国、日本、印度、韩国、澳洲和亚太地区其他地区）以及世界其他地区。到2022年，北美将在自膨式支架市场中占据压倒性占有率。北美完善的医疗基础设施、不断上涨的医疗成本以及不断增加的心血管疾病患者数量是推动北美市场成长的主要因素。

市场上营运的主要公司包括Boston Scientific Corporation、Medtronic、Cordis、Cook Medical、Biotronik, Inc.、Abbott、BD Interventional、Merit Medical Systems, Inc.、Terumo Corporation、Veryan Medical。

Self-expandable stents are medical devices used primarily in the field of interventional cardiology and vascular surgery to treat narrowed or blocked blood vessels. Unlike balloon-expandable stents that require inflation to deploy, self-expandable stents are designed to expand automatically upon insertion into the targeted vessel. This property makes them particularly useful in regions of the body where vessels are subject to movement or variation in diameter. The rising incidence of cardiovascular disorders, such as PAD and CAD, fuel the demand for interventional therapies like stent implantation, contributing to market expansion. For instance, as per the data of Certers for Disease Control and Prevention, 60% of the Amaercans are living with atleast one of the chronic disorder like heart disease, diabetes, or cancer. Further, about 650,000 deaths related to heart diasese were reported in United States during year 2021.

The Self-expandable Stents Market was valued at USD 3,200 Million in 2022 and is expected to grow at a CAGR of around 7.5% from 2023-2030.

Based on the product, the market is segmented into Carotid Self-expanding Stents, Gastrointestinal Self-expanding Stents, Endovascular Self-expandable Stents, and Others. The carotid self-expanding stents segment held the largest market share in 2022. Rising incidence of coronary artery disorders such as carotid artery stenosis etc. is acting as one of the major driver for the market.

On the basis of application, the market is categorized into Fem-Pop Artery, iliac Artery, Carotid Artery, Biliary, and Other. Among these, significant growth is observed in the carotid artery application which is mainly due to increasing adoption of carotid artery stenting (CAS) as an treatment option for carotid artery disease.

On the basis of end user, the market is categorized into Hospitals, Ambulatory Surgical Centers, and Others. Among these, exponential growth is observed in the ambulatory surgical centers which is mainly due to substantial presence of ambulatory surgical centers in various geographies and increasing preference of patients towards the ambulatory surgical centers for stenting related procedures.

For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North America held dominating share of Self-expandable Stents Market in 2022. The presence of well-established healthcare infrastructure, along with the increasing healthcare expenditure and rising cases of cardiovascular disorders in the countries is the major attributing factor for the market growth in North America.

Some of the major players operating in the market include Boston Scientific Corporation, Medtronic, Cordis, Cook Medical, Biotronik, Inc., Abbott, BD Interventional, Merit Medical Systems, Inc., Terumo Corporation, and Veryan Medical.

1.MARKET INTRODUCTION

1.1.Market Definitions
1.2.Main Objective
1.3.Stakeholders
1.4.Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

2.1.Research Process of the Self-expandable Stents Market
2.2.Research Methodology of the Self-expandable Stents Market
2.3.Respondent Profile

3.MARKET SYNOPSIS

4.EXECUTIVE SUMMARY

5.GLOBAL + COVID-19 IMPACT

6.GLOBAL SELF-EXPANDABLE STENTS MARKET REVENUE, 2020-2030F

7.MARKET INSIGHTS BY PRODUCT

7.1.Carotid Self-expanding Stents
7.2.Gastrointestinal Self-expanding Stents
7.3.Endovascular Self-expandable Stents
7.4.Others

8.MARKET INSIGHTS BY APPLICATION

8.1.Fem-Pop Artery
8.2.Iliac Artery
8.3.Carotid Artery
8.4.Biliary
8.5.Other

9.MARKET INSIGHTS BY END USER

9.1.Hospitals
9.2.Ambulatory Surgical Centers
9.3.Others

10.MARKET INSIGHTS BY REGION

10.1.North America Self-expandable Stents Market
- 10.1.1.U.S.
- 10.1.2.Canada
- 10.1.3.Rest of North America
10.2.Europe Self-expandable Stents Market
- 10.2.1.Germany
- 10.2.2.UK
- 10.2.3.France
- 10.2.4.Italy
- 10.2.5.Spain
- 10.2.6.Rest of Europe
10.3.Asia-Pacific Self-expandable Stents Market
- 10.3.1.China
- 10.3.2.Japan
- 10.3.3.India
- 10.3.4.Rest of APAC
10.4.Rest of the World Self-expandable Stents Market